Signup Crypto ETF Stocks News

Zefiro Appoints Catherine Flax as its Interim Chief Executive Officer

With decades of experience in Wall Street Banking, Catherine Flax brings a wealth of acumen and knowledge to the Zefiro organization as it continues to build out its market share as North America's largest single plugger of wells and an originator of high-quality carbon offsets.

Source: www.globenewswire.com
June 05, 2025 | 12:59:00
Category: News

Bread Financial Announces Early Tender Results of Its Previously Announced Cash Tender Offer

COLUMBUS, Ohio, June 05, 2025 ( GLOBE NEWSWIRE ) -- Bread Financial Holdings, Inc. ( NYSE: BFH ) ( "Bread Financial" or the "Company" ) announced that as of 5:00 p.m., New York City time, on June 4, 2025 ( the "Early Participation Date" ) , pursuant to and in accordance with its previously ...

Source: www.globenewswire.com
June 05, 2025 | 11:30:00
Category: News

Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®

Four presentations on MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, including two clinical data presentations ...

Source: www.globenewswire.com
June 05, 2025 | 11:30:00
Category: News

CTV Marks 24 Years as Canada's Most-Watched Conventional Network, as Compelling and Lighthearted New Series Join 2025/26 Schedule

- 9-1-1: NASHVILLE, BOSTON BLUE, THE FALL AND RISE OF REGGIE DINKINS, BEST MEDICINE, THE FLOOR, CELEBRITY WEAKEST LINK, and MEMORY OF A KILLER become part of CTV's most-watched schedule -- CTV Original series MASTERCHEF CANADA and THE TRAITORS CANADA are back with new seasons this fall, joined ...

Source: www.benzinga.com
June 05, 2025 | 11:30:00
Category: General

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025

Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program Highlights Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program Highlights ...

Source: www.globenewswire.com
June 05, 2025 | 11:30:00
Category: News

Cellebrite to Acquire Corellium - Cellebrite DI ( NASDAQ:CLBT )

TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 ( GLOBE NEWSWIRE ) -- Cellebrite CLBT, a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its agreement to acquire Corellium, a leader in Arm-based virtualization software.

Source: www.benzinga.com
June 05, 2025 | 11:30:00
Category: Mergers

Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress

- DYNE-302 Demonstrated Functional Improvement in an FSHD Preclinical Model ...

Source: www.globenewswire.com
June 05, 2025 | 11:30:00
Category: News

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ ( sodium oxybate ) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

DUBLIN, June 05, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM has been granted Orphan Drug Designation ( ODD ) from the U.S.

Source: www.globenewswire.com
June 05, 2025 | 11:30:00
Category: News

Bowman to Ring Nasdaq Opening Bell in Honor of 30th Anniversary - Bowman Consulting Group ( NASDAQ:BWMN )

RESTON, Va., June 05, 2025 ( GLOBE NEWSWIRE ) -- Bowman Consulting Group Ltd. BWMN, a national engineering services and program management firm, will ring the Nasdaq Stock Market opening bell on June 9, 2025, commemorating its 30th anniversary.

Source: www.benzinga.com
June 05, 2025 | 11:30:00
Category: News

Bowman to Ring Nasdaq Opening Bell in Honor of 30th Anniversary

Bowman will commemorate it's 30th anniversary by ringing the Nasdaq opening bell on Monday, June 9.

Source: www.globenewswire.com
June 05, 2025 | 11:30:00
Category: News

© Natavest 2025 - 2026